Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pax5
|
ENSMUSG00000014030.9 | paired box 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_44633810_44633961 | Pax5 | 11838 | 0.153778 | 0.31 | 2.1e-02 | Click! |
chr4_44704739_44704906 | Pax5 | 816 | 0.510541 | 0.06 | 6.6e-01 | Click! |
chr4_44703335_44703486 | Pax5 | 3 | 0.919669 | 0.04 | 7.8e-01 | Click! |
chr4_44704190_44704704 | Pax5 | 441 | 0.736386 | -0.00 | 1.0e+00 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_90775730_90776099 | 6.95 |
Col6a3 |
collagen, type VI, alpha 3 |
2699 |
0.31 |
chr2_27774078_27774756 | 4.34 |
Rxra |
retinoid X receptor alpha |
34216 |
0.19 |
chr9_106356672_106356994 | 3.20 |
Dusp7 |
dual specificity phosphatase 7 |
11799 |
0.12 |
chr9_23222547_23223976 | 3.15 |
Bmper |
BMP-binding endothelial regulator |
25 |
0.99 |
chr19_61225302_61226760 | 2.89 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chrX_73465571_73465805 | 2.86 |
Haus7 |
HAUS augmin-like complex, subunit 7 |
6644 |
0.12 |
chr11_76374871_76375078 | 2.58 |
Nxn |
nucleoredoxin |
24094 |
0.16 |
chr11_94881938_94882392 | 2.50 |
A430060F13Rik |
RIKEN cDNA A430060F13 gene |
20406 |
0.11 |
chr8_85554792_85555798 | 2.24 |
Dnaja2 |
DnaJ heat shock protein family (Hsp40) member A2 |
49 |
0.97 |
chr8_85365297_85365473 | 2.22 |
Mylk3 |
myosin light chain kinase 3 |
38 |
0.97 |
chr11_89672668_89672824 | 2.05 |
Ankfn1 |
ankyrin-repeat and fibronectin type III domain containing 1 |
24099 |
0.27 |
chr1_90690581_90690778 | 1.95 |
Gm9991 |
predicted gene 9991 |
15518 |
0.22 |
chr2_166399693_166399946 | 1.94 |
Gm14268 |
predicted gene 14268 |
1632 |
0.43 |
chr12_111907471_111908935 | 1.92 |
Ppp1r13b |
protein phosphatase 1, regulatory subunit 13B |
93 |
0.95 |
chr11_61484326_61485106 | 1.85 |
Mfap4 |
microfibrillar-associated protein 4 |
715 |
0.53 |
chr11_4572974_4574056 | 1.78 |
Gm11960 |
predicted gene 11960 |
9883 |
0.16 |
chr9_58487820_58488921 | 1.77 |
Insyn1 |
inhibitory synaptic factor 1 |
233 |
0.93 |
chr15_98180977_98181745 | 1.75 |
Olfr288 |
olfactory receptor 288 |
14084 |
0.1 |
chr2_92012824_92013103 | 1.75 |
Creb3l1 |
cAMP responsive element binding protein 3-like 1 |
11539 |
0.14 |
chr2_165992309_165993441 | 1.74 |
Ncoa3 |
nuclear receptor coactivator 3 |
238 |
0.61 |
chr2_26139656_26141133 | 1.73 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chr11_94246406_94247057 | 1.73 |
Wfikkn2 |
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 |
726 |
0.63 |
chr8_89283531_89283682 | 1.70 |
Gm5356 |
predicted pseudogene 5356 |
96046 |
0.08 |
chr7_112130026_112130177 | 1.69 |
Dkk3 |
dickkopf WNT signaling pathway inhibitor 3 |
28956 |
0.2 |
chr6_125355161_125355725 | 1.68 |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
1928 |
0.22 |
chr3_133235113_133235336 | 1.68 |
Arhgef38 |
Rho guanine nucleotide exchange factor (GEF) 38 |
275 |
0.93 |
chr8_25440811_25441078 | 1.68 |
Gm45237 |
predicted gene 45237 |
37 |
0.96 |
chr1_74031473_74031909 | 1.68 |
Tns1 |
tensin 1 |
5442 |
0.25 |
chr9_66592430_66593671 | 1.67 |
Usp3 |
ubiquitin specific peptidase 3 |
14 |
0.98 |
chr8_92505647_92506163 | 1.67 |
Gm45336 |
predicted gene 45336 |
40138 |
0.18 |
chr6_92635217_92635368 | 1.67 |
Prickle2 |
prickle planar cell polarity protein 2 |
67926 |
0.11 |
chr13_3709274_3709697 | 1.66 |
Gm47695 |
predicted gene, 47695 |
50340 |
0.09 |
chr8_124340552_124340748 | 1.65 |
Gm15775 |
predicted gene 15775 |
8855 |
0.15 |
chr13_3694702_3694868 | 1.63 |
Gm23084 |
predicted gene, 23084 |
46248 |
0.1 |
chr17_27916509_27916660 | 1.63 |
Taf11 |
TATA-box binding protein associated factor 11 |
6740 |
0.11 |
chr15_63340480_63340689 | 1.63 |
Gm41335 |
predicted gene, 41335 |
16435 |
0.25 |
chr11_84659326_84659731 | 1.63 |
1700109G15Rik |
RIKEN cDNA 1700109G15 gene |
60904 |
0.11 |
chr10_77417184_77418713 | 1.62 |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
94 |
0.97 |
chr17_42576566_42577176 | 1.61 |
Opn5 |
opsin 5 |
34524 |
0.22 |
chr13_51280471_51280638 | 1.59 |
Gm6056 |
predicted gene 6056 |
58367 |
0.1 |
chr2_26594675_26595827 | 1.59 |
Egfl7 |
EGF-like domain 7 |
3104 |
0.11 |
chr14_11863272_11863596 | 1.57 |
Gm48601 |
predicted gene, 48601 |
4160 |
0.28 |
chr4_83052208_83052412 | 1.55 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
29 |
0.98 |
chr1_172221317_172221900 | 1.55 |
Casq1 |
calsequestrin 1 |
1740 |
0.2 |
chr7_34570196_34571084 | 1.54 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr11_117296657_117296938 | 1.54 |
Septin9 |
septin 9 |
11357 |
0.19 |
chr10_82690601_82690795 | 1.52 |
Glt8d2 |
glycosyltransferase 8 domain containing 2 |
48 |
0.97 |
chr11_94933593_94934009 | 1.50 |
Col1a1 |
collagen, type I, alpha 1 |
2423 |
0.19 |
chr8_122281269_122282287 | 1.50 |
Zfpm1 |
zinc finger protein, multitype 1 |
363 |
0.84 |
chr6_92942901_92944022 | 1.49 |
Adamts9 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9 |
31 |
0.98 |
chrX_143966253_143966591 | 1.49 |
Dcx |
doublecortin |
33111 |
0.21 |
chr15_27815085_27815264 | 1.48 |
Trio |
triple functional domain (PTPRF interacting) |
8609 |
0.22 |
chr1_151891231_151891444 | 1.48 |
Gm28610 |
predicted gene 28610 |
15918 |
0.19 |
chr18_78238166_78238597 | 1.47 |
Slc14a2 |
solute carrier family 14 (urea transporter), member 2 |
29287 |
0.22 |
chr9_25527469_25527743 | 1.47 |
Gm25861 |
predicted gene, 25861 |
11599 |
0.2 |
chr15_85172092_85172407 | 1.46 |
Gm19277 |
predicted gene, 19277 |
16117 |
0.14 |
chrX_11739660_11739811 | 1.46 |
Gm14513 |
predicted gene 14513 |
55611 |
0.14 |
chr9_67192121_67192284 | 1.45 |
Tln2 |
talin 2 |
39205 |
0.13 |
chr4_123664091_123665178 | 1.45 |
Macf1 |
microtubule-actin crosslinking factor 1 |
118 |
0.93 |
chr5_134539942_134540283 | 1.45 |
Gm42884 |
predicted gene 42884 |
11945 |
0.1 |
chr10_77498333_77498670 | 1.45 |
Fam207a |
family with sequence similarity 207, member A |
8814 |
0.14 |
chr9_55511545_55512716 | 1.44 |
Etfa |
electron transferring flavoprotein, alpha polypeptide |
10 |
0.97 |
chr7_19409764_19410098 | 1.44 |
Ckm |
creatine kinase, muscle |
1094 |
0.24 |
chr1_91022595_91022824 | 1.44 |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
23930 |
0.15 |
chr6_71989913_71990094 | 1.44 |
Gm26628 |
predicted gene, 26628 |
26228 |
0.11 |
chr13_15741859_15742225 | 1.44 |
Gm48408 |
predicted gene, 48408 |
28078 |
0.16 |
chr11_50377311_50377861 | 1.44 |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
133 |
0.94 |
chr18_13560776_13561017 | 1.43 |
AC103362.1 |
novel transcript |
40504 |
0.21 |
chr16_34935883_34936269 | 1.43 |
1700119H24Rik |
RIKEN cDNA 1700119H24 gene |
3253 |
0.22 |
chr11_82139815_82139966 | 1.43 |
Ccl8 |
chemokine (C-C motif) ligand 8 |
24705 |
0.15 |
chr9_106355974_106356661 | 1.42 |
Dusp7 |
dual specificity phosphatase 7 |
12315 |
0.12 |
chr13_53178665_53178847 | 1.41 |
Ror2 |
receptor tyrosine kinase-like orphan receptor 2 |
96902 |
0.07 |
chr1_134037329_134037507 | 1.41 |
Fmod |
fibromodulin |
78 |
0.96 |
chr15_37960550_37961674 | 1.41 |
Rrm2b |
ribonucleotide reductase M2 B (TP53 inducible) |
9 |
0.92 |
chr6_82957102_82957253 | 1.40 |
Gm19287 |
predicted gene, 19287 |
4397 |
0.11 |
chr15_83223251_83223918 | 1.40 |
A4galt |
alpha 1,4-galactosyltransferase |
28145 |
0.1 |
chr5_140641343_140641536 | 1.40 |
Ttyh3 |
tweety family member 3 |
4972 |
0.16 |
chr11_75013005_75013592 | 1.39 |
Smg6 |
Smg-6 homolog, nonsense mediated mRNA decay factor (C. elegans) |
19445 |
0.11 |
chr19_10297046_10297647 | 1.38 |
Gm30042 |
predicted gene, 30042 |
6420 |
0.15 |
chr8_83681208_83681373 | 1.37 |
Pkn1 |
protein kinase N1 |
299 |
0.83 |
chr18_61665433_61665940 | 1.37 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
149 |
0.92 |
chr5_103029055_103029485 | 1.36 |
Mapk10 |
mitogen-activated protein kinase 10 |
2275 |
0.37 |
chr9_30520954_30521361 | 1.36 |
Rps2-ps12 |
ribosomal protein S2, pseudogene 12 |
8217 |
0.22 |
chr5_108703742_108704173 | 1.36 |
Fgfrl1 |
fibroblast growth factor receptor-like 1 |
1117 |
0.36 |
chr8_34163517_34163668 | 1.36 |
Mir6395 |
microRNA 6395 |
3120 |
0.14 |
chr16_20534822_20536370 | 1.35 |
Ap2m1 |
adaptor-related protein complex 2, mu 1 subunit |
47 |
0.93 |
chr4_71131009_71131663 | 1.35 |
Gm11228 |
predicted gene 11228 |
203 |
0.96 |
chr14_65676139_65676351 | 1.34 |
Scara5 |
scavenger receptor class A, member 5 |
232 |
0.95 |
chr6_72750837_72750988 | 1.34 |
Gm37736 |
predicted gene, 37736 |
1002 |
0.5 |
chr4_136220547_136220733 | 1.33 |
Asap3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
14275 |
0.13 |
chr19_55165239_55165390 | 1.33 |
Tectb |
tectorin beta |
15419 |
0.17 |
chr19_10688263_10689591 | 1.33 |
Vps37c |
vacuolar protein sorting 37C |
162 |
0.91 |
chr2_119996069_119996220 | 1.32 |
Mapkbp1 |
mitogen-activated protein kinase binding protein 1 |
15543 |
0.11 |
chr9_61163761_61164250 | 1.32 |
I730028E13Rik |
RIKEN cDNA I730028E13 gene |
25490 |
0.14 |
chr8_11328050_11328201 | 1.32 |
Col4a1 |
collagen, type IV, alpha 1 |
15299 |
0.15 |
chr2_10755408_10755808 | 1.31 |
Gm18547 |
predicted gene, 18547 |
138101 |
0.02 |
chr1_91611287_91611438 | 1.30 |
Gm28380 |
predicted gene 28380 |
44 |
0.98 |
chr13_32630202_32630413 | 1.29 |
AL645799.1 |
novel transcript |
16291 |
0.23 |
chr9_67114163_67114314 | 1.29 |
Gm22145 |
predicted gene, 22145 |
10030 |
0.16 |
chr8_26358776_26358947 | 1.29 |
Gm31784 |
predicted gene, 31784 |
46527 |
0.1 |
chr9_107981626_107982218 | 1.29 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
1032 |
0.19 |
chr14_30360488_30360854 | 1.28 |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
7144 |
0.17 |
chr2_28446566_28447382 | 1.28 |
Ppp1r26 |
protein phosphatase 1, regulatory subunit 26 |
108 |
0.95 |
chr8_27061810_27062236 | 1.28 |
Plpbp |
pyridoxal phosphate binding protein |
11249 |
0.1 |
chr17_46104525_46104933 | 1.28 |
Mrps18a |
mitochondrial ribosomal protein S18A |
6257 |
0.12 |
chr12_109502508_109502659 | 1.28 |
Gm34081 |
predicted gene, 34081 |
14157 |
0.06 |
chr16_18555321_18555528 | 1.27 |
Gnb1l |
guanine nucleotide binding protein (G protein), beta polypeptide 1-like |
6681 |
0.13 |
chr2_77816275_77817277 | 1.27 |
Zfp385b |
zinc finger protein 385B |
40 |
0.98 |
chr11_116412390_116413178 | 1.27 |
Rnf157 |
ring finger protein 157 |
220 |
0.88 |
chr15_97938586_97938737 | 1.26 |
Tmem106c |
transmembrane protein 106C |
25539 |
0.14 |
chr1_134006226_134006456 | 1.25 |
Gm18970 |
predicted gene, 18970 |
27037 |
0.12 |
chr18_77064765_77065970 | 1.25 |
Pias2 |
protein inhibitor of activated STAT 2 |
122 |
0.97 |
chr7_49567577_49567914 | 1.25 |
Nav2 |
neuron navigator 2 |
7395 |
0.27 |
chr11_72370286_72370512 | 1.24 |
Tekt1 |
tektin 1 |
7957 |
0.13 |
chr11_102819100_102819714 | 1.24 |
Gjc1 |
gap junction protein, gamma 1 |
197 |
0.89 |
chr10_41293067_41293416 | 1.24 |
Fig4 |
FIG4 phosphoinositide 5-phosphatase |
10019 |
0.16 |
chr13_112346921_112347140 | 1.24 |
Gm48837 |
predicted gene, 48837 |
20815 |
0.15 |
chr14_49348147_49348502 | 1.23 |
Slc35f4 |
solute carrier family 35, member F4 |
34115 |
0.16 |
chr2_30865207_30865358 | 1.23 |
Prrx2 |
paired related homeobox 2 |
14037 |
0.12 |
chr5_122621322_122621633 | 1.23 |
Ift81 |
intraflagellar transport 81 |
6959 |
0.13 |
chr11_118324654_118324805 | 1.23 |
Cep295nl |
CEP295 N-terminal like |
9287 |
0.16 |
chr2_3283505_3284761 | 1.23 |
Nmt2 |
N-myristoyltransferase 2 |
79 |
0.97 |
chr7_142552592_142553192 | 1.23 |
Nctc1 |
non-coding transcript 1 |
5704 |
0.11 |
chr1_72969201_72969398 | 1.22 |
1700027A15Rik |
RIKEN cDNA 1700027A15 gene |
15545 |
0.22 |
chr5_73775861_73776036 | 1.22 |
Spata18 |
spermatogenesis associated 18 |
116687 |
0.05 |
chr8_104606382_104606800 | 1.22 |
Cdh16 |
cadherin 16 |
6673 |
0.1 |
chr1_90690831_90691200 | 1.22 |
Gm9991 |
predicted gene 9991 |
15854 |
0.22 |
chr4_146474716_146475577 | 1.22 |
Gm13241 |
predicted gene 13241 |
186 |
0.92 |
chr2_27096245_27096402 | 1.22 |
Adamtsl2 |
ADAMTS-like 2 |
973 |
0.43 |
chr5_21544954_21545105 | 1.22 |
Lrrc17 |
leucine rich repeat containing 17 |
1466 |
0.4 |
chrX_106898018_106898169 | 1.21 |
Lpar4 |
lysophosphatidic acid receptor 4 |
22532 |
0.19 |
chr1_85588537_85589247 | 1.21 |
Sp110 |
Sp110 nuclear body protein |
299 |
0.81 |
chr11_102991644_102991929 | 1.20 |
Dcakd |
dephospho-CoA kinase domain containing |
5762 |
0.12 |
chr2_103685200_103685481 | 1.20 |
Abtb2 |
ankyrin repeat and BTB (POZ) domain containing 2 |
29695 |
0.14 |
chr12_3834339_3834973 | 1.20 |
Dnmt3a |
DNA methyltransferase 3A |
14979 |
0.17 |
chr8_105170389_105171616 | 1.20 |
Cbfb |
core binding factor beta |
57 |
0.94 |
chr7_112144830_112145060 | 1.20 |
Dkk3 |
dickkopf WNT signaling pathway inhibitor 3 |
14112 |
0.24 |
chr15_66891426_66891612 | 1.19 |
Ccn4 |
cellular communication network factor 4 |
11 |
0.98 |
chr8_122284023_122284944 | 1.19 |
Zfpm1 |
zinc finger protein, multitype 1 |
2342 |
0.24 |
chr4_134156862_134157025 | 1.19 |
Cep85 |
centrosomal protein 85 |
22 |
0.95 |
chr13_17086575_17086801 | 1.18 |
Gm27043 |
predicted gene, 27043 |
35767 |
0.2 |
chr9_75654699_75654894 | 1.18 |
Gm37871 |
predicted gene, 37871 |
11856 |
0.14 |
chr5_113418514_113418665 | 1.18 |
Aym1 |
activator of yeast meiotic promoters 1 |
61295 |
0.09 |
chr7_99356524_99357152 | 1.18 |
Serpinh1 |
serine (or cysteine) peptidase inhibitor, clade H, member 1 |
3599 |
0.18 |
chr16_4658564_4659219 | 1.18 |
Coro7 |
coronin 7 |
3031 |
0.16 |
chr11_51855495_51856955 | 1.18 |
Jade2 |
jade family PHD finger 2 |
900 |
0.57 |
chr18_20190952_20191121 | 1.17 |
Dsg1c |
desmoglein 1 gamma |
56304 |
0.13 |
chr18_38907790_38908188 | 1.17 |
Fgf1 |
fibroblast growth factor 1 |
10782 |
0.2 |
chr2_32329650_32329801 | 1.17 |
Dnm1 |
dynamin 1 |
9144 |
0.08 |
chr16_34494091_34494303 | 1.16 |
Kalrn |
kalirin, RhoGEF kinase |
19747 |
0.27 |
chr7_98784649_98784842 | 1.16 |
Gm44934 |
predicted gene 44934 |
49664 |
0.09 |
chr12_10231676_10231890 | 1.16 |
Gm48792 |
predicted gene, 48792 |
9454 |
0.23 |
chr15_12068261_12068412 | 1.16 |
Gm34759 |
predicted gene, 34759 |
16861 |
0.15 |
chr12_102291801_102291978 | 1.16 |
Rin3 |
Ras and Rab interactor 3 |
8248 |
0.22 |
chr2_167569996_167570220 | 1.16 |
Gm11476 |
predicted gene 11476 |
16794 |
0.11 |
chr7_45784749_45786509 | 1.16 |
Lmtk3 |
lemur tyrosine kinase 3 |
119 |
0.87 |
chr4_131920531_131921931 | 1.15 |
Tmem200b |
transmembrane protein 200B |
31 |
0.78 |
chr16_21271708_21272073 | 1.15 |
Mir7680 |
microRNA 7680 |
15824 |
0.15 |
chr1_91801146_91801763 | 1.15 |
Twist2 |
twist basic helix-loop-helix transcription factor 2 |
7 |
0.97 |
chr6_72750999_72751150 | 1.15 |
Gm37736 |
predicted gene, 37736 |
840 |
0.57 |
chr19_36553934_36555231 | 1.15 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr5_103387516_103387737 | 1.15 |
5430427N15Rik |
RIKEN cDNA 5430427N15 gene |
30928 |
0.13 |
chr5_111770196_111770736 | 1.15 |
E130006D01Rik |
RIKEN cDNA E130006D01 gene |
8741 |
0.18 |
chr6_37415105_37415455 | 1.15 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
26866 |
0.23 |
chr11_52272220_52272371 | 1.14 |
Tcf7 |
transcription factor 7, T cell specific |
2582 |
0.2 |
chr6_72711151_72711562 | 1.14 |
Gm15402 |
predicted gene 15402 |
12142 |
0.13 |
chr15_84639758_84640293 | 1.14 |
Prr5 |
proline rich 5 (renal) |
29595 |
0.16 |
chr2_12221651_12222208 | 1.14 |
Itga8 |
integrin alpha 8 |
20535 |
0.21 |
chr9_30879873_30880049 | 1.14 |
Adamts15 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 15 |
29696 |
0.18 |
chr1_74068437_74069385 | 1.14 |
Tns1 |
tensin 1 |
22440 |
0.17 |
chr2_173801485_173801800 | 1.14 |
Vapb |
vesicle-associated membrane protein, associated protein B and C |
33442 |
0.14 |
chr8_125368418_125368617 | 1.14 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
124193 |
0.05 |
chr2_150770474_150770661 | 1.14 |
Pygb |
brain glycogen phosphorylase |
16168 |
0.13 |
chr1_88261034_88262277 | 1.13 |
Mroh2a |
maestro heat-like repeat family member 2A |
3897 |
0.12 |
chr8_36697853_36698026 | 1.13 |
Dlc1 |
deleted in liver cancer 1 |
35115 |
0.22 |
chr10_61978410_61978597 | 1.13 |
Col13a1 |
collagen, type XIII, alpha 1 |
382 |
0.86 |
chr9_61164915_61165148 | 1.12 |
I730028E13Rik |
RIKEN cDNA I730028E13 gene |
26516 |
0.14 |
chr1_187907999_187908167 | 1.12 |
Esrrg |
estrogen-related receptor gamma |
89744 |
0.09 |
chr5_130938531_130938696 | 1.12 |
Gm42896 |
predicted gene 42896 |
21422 |
0.2 |
chr7_19695060_19695492 | 1.12 |
Apoe |
apolipoprotein E |
2355 |
0.11 |
chr7_143376055_143376238 | 1.12 |
4933417O13Rik |
RIKEN cDNA 4933417O13 gene |
11521 |
0.14 |
chr6_91236082_91236291 | 1.12 |
Fbln2 |
fibulin 2 |
19815 |
0.15 |
chr17_28345476_28345836 | 1.12 |
Tead3 |
TEA domain family member 3 |
4690 |
0.11 |
chr9_41614121_41614312 | 1.11 |
Gm48737 |
predicted gene, 48737 |
4776 |
0.13 |
chr19_56660703_56660854 | 1.11 |
Gm32441 |
predicted gene, 32441 |
3833 |
0.21 |
chr4_100219370_100219521 | 1.11 |
Gm12701 |
predicted gene 12701 |
99824 |
0.07 |
chr18_62044092_62044268 | 1.11 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
66221 |
0.1 |
chr18_58555526_58555994 | 1.11 |
Slc27a6 |
solute carrier family 27 (fatty acid transporter), member 6 |
497 |
0.86 |
chr2_64172372_64172844 | 1.10 |
Fign |
fidgetin |
74570 |
0.13 |
chr12_4213027_4213178 | 1.10 |
Cenpo |
centromere protein O |
3404 |
0.13 |
chr19_58860384_58861477 | 1.10 |
Hspa12a |
heat shock protein 12A |
37 |
0.98 |
chr11_8656803_8657098 | 1.10 |
Tns3 |
tensin 3 |
7585 |
0.31 |
chr13_73261107_73261258 | 1.10 |
Irx4 |
Iroquois homeobox 4 |
685 |
0.65 |
chr19_55165003_55165154 | 1.09 |
Tectb |
tectorin beta |
15655 |
0.17 |
chr10_59566259_59566449 | 1.09 |
Gm10322 |
predicted gene 10322 |
49709 |
0.13 |
chr12_28120180_28120346 | 1.09 |
Gm25923 |
predicted gene, 25923 |
59735 |
0.14 |
chr6_72188837_72189690 | 1.09 |
Gm38832 |
predicted gene, 38832 |
26414 |
0.13 |
chr19_44642421_44642572 | 1.08 |
Gm35460 |
predicted gene, 35460 |
27731 |
0.13 |
chr6_124856418_124856707 | 1.08 |
P3h3 |
prolyl 3-hydroxylase 3 |
1167 |
0.24 |
chr3_79628270_79629417 | 1.08 |
Etfdh |
electron transferring flavoprotein, dehydrogenase |
20 |
0.75 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.9 | 2.6 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.7 | 1.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.6 | 1.9 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.6 | 5.7 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.6 | 4.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 2.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.5 | 1.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 1.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 1.5 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.5 | 1.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.4 | 2.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 1.8 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.4 | 1.3 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.4 | 1.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 1.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 1.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 0.4 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.4 | 2.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.4 | 1.1 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.4 | 1.4 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.4 | 2.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.4 | 1.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 0.7 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 0.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 1.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 1.0 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.3 | 0.3 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.3 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 1.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.3 | 1.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 0.9 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 0.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.3 | 0.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 0.9 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 1.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 3.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 0.3 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.3 | 0.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 0.3 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.3 | 0.9 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.3 | 1.7 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.3 | 1.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 1.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 1.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 1.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 0.8 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.3 | 1.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 1.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 0.5 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.3 | 0.3 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
0.3 | 1.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.3 | 0.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 | 0.8 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 0.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 1.0 | GO:2000065 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.3 | 0.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 0.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 0.5 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.2 | 0.7 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 1.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 1.4 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.2 | 0.5 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.2 | 1.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 0.5 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.9 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.2 | 0.2 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.2 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 1.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 0.9 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 0.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 1.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.9 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.6 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 0.6 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 0.4 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 0.4 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.2 | 0.4 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.2 | 1.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 2.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.4 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.2 | 0.4 | GO:0051794 | regulation of catagen(GO:0051794) |
0.2 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 1.4 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.2 | 0.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 1.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 2.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 0.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 3.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 1.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 1.0 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 0.6 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 0.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.8 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.2 | 0.4 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.2 | 0.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.2 | 0.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 2.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 1.5 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.2 | 0.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.4 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.2 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 3.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 1.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.7 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.9 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 1.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 0.7 | GO:0009180 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.2 | 0.7 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.2 | 1.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.7 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.2 | 0.5 | GO:1902338 | negative regulation of apoptotic process involved in morphogenesis(GO:1902338) |
0.2 | 0.7 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.2 | 0.7 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.5 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.2 | 0.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.2 | 1.3 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.2 | 0.2 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.2 | 1.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 0.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 0.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.2 | 0.9 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 0.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 0.6 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 0.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.6 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.6 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.4 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.1 | 0.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.6 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 1.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 1.0 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 3.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.3 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.5 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.1 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.8 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.6 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.9 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.3 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.3 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.8 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.1 | 0.3 | GO:0003166 | bundle of His development(GO:0003166) |
0.1 | 0.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.1 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.1 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 0.2 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.1 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.4 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.1 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.1 | 0.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.7 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.2 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.1 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.7 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.3 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 2.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.2 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.1 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.3 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.9 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.2 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.1 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.1 | 0.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.3 | GO:0048840 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.1 | 0.3 | GO:0033483 | gas homeostasis(GO:0033483) |
0.1 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.8 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.3 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.1 | 0.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.1 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.1 | 0.5 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.5 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.2 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.3 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.2 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.5 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.5 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 1.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.4 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.2 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 1.0 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.1 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.9 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.1 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.1 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) positive regulation of interleukin-18 production(GO:0032741) |
0.1 | 0.5 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.1 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.6 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.6 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 1.2 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.2 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.1 | 0.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.5 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.5 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.1 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.1 | 0.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 1.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.8 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.2 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.4 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.1 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.4 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.1 | 0.1 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) |
0.1 | 0.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.4 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.2 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.2 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.3 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.9 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.7 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.1 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.1 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) brain renin-angiotensin system(GO:0002035) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.9 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.2 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 1.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.1 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.8 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.2 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.1 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.2 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.3 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.1 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.1 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 0.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.4 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.2 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 1.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.5 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.2 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.0 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.0 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.0 | 0.0 | GO:0071655 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.0 | 0.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.3 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.0 | 0.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.1 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.3 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 3.1 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.1 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.3 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.0 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.2 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.0 | GO:1903909 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of receptor clustering(GO:1903909) positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.0 | 0.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.1 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0035483 | gastric emptying(GO:0035483) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.1 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.0 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 1.6 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.7 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.0 | 0.1 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.0 | 0.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 0.2 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.2 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 1.1 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.0 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.0 | 0.1 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.0 | 0.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.0 | 0.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.0 | 0.0 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.1 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.2 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.0 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.0 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.0 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.1 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 0.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.3 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 0.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.5 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.2 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.5 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.0 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.6 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.0 | 0.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.5 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.3 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.0 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.0 | 0.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.0 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.1 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.0 | 0.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.0 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.0 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.4 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.0 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.0 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.0 | 0.1 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.2 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.0 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.0 | 0.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.0 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.1 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.2 | GO:0043144 | snoRNA processing(GO:0043144) |
0.0 | 0.3 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.0 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.0 | 0.1 | GO:1902267 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.0 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.0 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.2 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.0 | 0.3 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.0 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.0 | 0.1 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.0 | 0.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 0.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.0 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.0 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.0 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.0 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.6 | 2.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 4.3 | GO:0005861 | troponin complex(GO:0005861) |
0.5 | 1.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 4.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 2.0 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 5.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 5.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 0.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.8 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 1.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.4 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 1.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 3.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 7.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 1.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 1.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.7 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 7.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.4 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 1.2 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.9 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.5 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 1.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 1.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 4.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.5 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 22.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 1.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.1 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 2.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 1.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 1.0 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 1.0 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 1.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 1.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 7.4 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 1.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 1.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 2.3 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.9 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.3 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 2.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 2.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 1.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.5 | 1.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.5 | 5.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 1.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.4 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 1.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.0 | GO:0018590 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.3 | 1.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 1.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 2.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 0.9 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 3.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 0.9 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 0.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 1.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 1.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 1.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 0.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 1.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 2.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 0.8 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 1.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 2.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.2 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.2 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 1.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 0.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 0.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.2 | 0.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 2.1 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.5 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 1.8 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 1.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 2.4 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 9.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 1.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 4.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 0.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 1.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.3 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 1.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 1.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.1 | 2.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 2.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 3.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 3.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 1.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 2.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.9 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.5 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.9 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 1.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 2.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.5 | GO:0018630 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.3 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.1 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 2.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 1.2 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.7 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 5.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 5.9 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 1.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.6 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 0.7 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 1.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 1.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 10.3 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 2.9 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.0 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 3.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 1.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 1.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 1.2 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.0 | 0.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.0 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.1 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.0 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0005165 | neurotrophin receptor binding(GO:0005165) neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.0 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 2.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.2 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.6 | GO:0017095 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.0 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.3 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 1.1 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 1.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.7 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 12.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 9.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 3.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 2.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 2.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 13.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 2.7 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 7.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 14.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 7.0 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.2 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.3 | 8.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 13.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 2.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 0.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 1.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 1.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 5.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 2.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 1.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 1.0 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.1 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.0 | 0.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 1.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 2.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.6 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.0 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |